176 related articles for article (PubMed ID: 18755211)
1. Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.
Tallett AJ; Blundell JE; Rodgers RJ
Pharmacol Biochem Behav; 2009 Jan; 91(3):358-66. PubMed ID: 18755211
[TBL] [Abstract][Full Text] [Related]
2. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
Tallett AJ; Blundell JE; Rodgers JR
Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
[TBL] [Abstract][Full Text] [Related]
3. Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.
Tallett AJ; Blundell JE; Rodgers RJ
Physiol Behav; 2008 Jun; 94(3):422-31. PubMed ID: 18394662
[TBL] [Abstract][Full Text] [Related]
4. Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
Wright FL; Rodgers RJ
Psychopharmacology (Berl); 2013 Mar; 226(2):415-31. PubMed ID: 23142959
[TBL] [Abstract][Full Text] [Related]
5. Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
Tallett AJ; Blundell JE; Rodgers RJ
Psychopharmacology (Berl); 2007 Nov; 195(1):27-39. PubMed ID: 17639351
[TBL] [Abstract][Full Text] [Related]
6. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.
Rowland NE; Mukherjee M; Robertson K
Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078
[TBL] [Abstract][Full Text] [Related]
7. Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2010 Feb; 207(1):174-81. PubMed ID: 19818809
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.
Ward SJ; Lefever TW; Rawls SM; Whiteside GT; Walker EA
Psychopharmacology (Berl); 2009 Sep; 206(1):155-65. PubMed ID: 19575185
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
10. Synergistic efects of opioid and cannabinoid antagonists on food intake.
Kirkham TC; Williams CM
Psychopharmacology (Berl); 2001 Jan; 153(2):267-70. PubMed ID: 11205430
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats.
Tallett AJ; Blundell JE; Rodgers RJ
Pharmacol Biochem Behav; 2010 Nov; 97(1):92-100. PubMed ID: 20026165
[TBL] [Abstract][Full Text] [Related]
12. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats.
McLaughlin PJ; Winston KM; Limebeer CL; Parker LA; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 2005 Jul; 180(2):286-93. PubMed ID: 15948012
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.
Hodge J; Bow JP; Plyler KS; Vemuri VK; Wisniecki A; Salamone JD; Makriyannis A; McLaughlin PJ
Behav Brain Res; 2008 Nov; 193(2):298-305. PubMed ID: 18602425
[TBL] [Abstract][Full Text] [Related]
14. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.
Rutkowska M
Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
16. Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.
Tallett AJ; Blundell JE; Rodgers RJ
Behav Brain Res; 2008 Mar; 187(2):417-27. PubMed ID: 18022706
[TBL] [Abstract][Full Text] [Related]
17. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
18. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
Bojanowska E; Radziszewska E
J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
[TBL] [Abstract][Full Text] [Related]
19. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of combination treatment with leptin and cannabinoid CB1 receptor agonist on food intake and body weight gain is mediated by serotonin 1B and 2C receptors.
Wierucka-Rybak M; Wolak M; Juszczak M; Drobnik J; Bojanowska E
J Physiol Pharmacol; 2016 Jun; 67(3):457-63. PubMed ID: 27512006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]